glp 1 agonist and blindness GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GLP1 Receptor Agonists—Effects beyond Obesity

Name: glp 1 agonist and blindness GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GLP1 Receptor Agonists—Effects beyond Obesity
Brand: clickpoint.com.au
SKU: 37991608381
Price: 20.03 USD
Availability: InStock
Rating: 4.6138 (23 reviews)

SKU: 37991608381

4.6

USD20.03 USD56.03

Pay in 4 interest-free payments of $5.01 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

GLP1 Receptor AgonistsEffects beyond Obesity and Diabetes Dual GIP GLP 1 receptor agonists: New advances for treating type 2 diabetes ScienceDirect Central glucagon like peptide 1 receptor activation inhibits Toll like receptor agonist induced inflammation ScienceDirect Ozempic Blindness: Should You Worry? GoodRx Possible Link Between GLP 1 RA Medications & Eye Health GLP 1 Medications and NAION: What Patients Should Know About Sudden Vision Loss

Store: clickpoint.com.au · Domain: clickpoint.com.au

Description

Briefly, for each target, after calculating the chemical descriptors of the collected molecular activity data using the previously described method, these descriptors served as features, while the activity values were used as labels for training